| http://www.w3.org/ns/prov#value | - Nevertheless, experience in Europe suggests that there is a grave risk of primary pulmonary hypertension (PPH) from fenfluramine, whether dispensed as the racemic mixture or the pure D-isomer.2 Even though the risk for PPH is small, the mortality is high, the results of treatment are uncertain, and there is no proven screening method.I have treated 557 patients with a variation of the phen-fen c
|
